Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fabrication and Application of Copper Metal–Organic Frameworks As Nanocarriers for Ph-Responsive Anticancer Drug Delivery Publisher



Gharehdaghi Z1 ; Rahimi R1 ; Naghib SM2 ; Molaabasi F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran
  2. 2. Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology (IUST), Tehran, Iran
  3. 3. Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

Source: Journal of the Iranian Chemical Society Published:2022


Abstract

Copper-based metal−organic frameworks (Cu-MOFs) have been extensively used in delivery of several therapeutics because of their cytocompatibility, favorable degradation and structural flexibility. In this work, we investigated two types of Cu-MOF-based nanocomposites including GO/Cu-TCPP and Fe3O4@Cu3(BTC)2 for loading of doxorubicin (DOX) and pH-sensitive release of the drug in vitro. The Fe3O4@Cu3(BTC)2 is an octahedron network structure, while the GO/Cu-TCPP nanocomposite consists of copper (II)-porphyrin metal–organic framework (Cu-TCPP) crystals embedded between exfoliated graphene oxide (GO) layers. Our studies show that GO/Cu-TCPP has adsorbed more doxorubicin (DOX) (45.7 wt.%) compared to Fe3O4@Cu3(BTC)2 (40.5 wt.%). More drug loading for Cu3(BTC)2 was also obtained than that of Cu-TCPP. For GO/Cu-TCPP at pH 5, 98.9% of DOX released for 60 h and 33.5% of DOX released after 60 h at pH 7.4, while the released amount of DOX from Fe3O4@Cu3(BTC)2 at pH 5 reached 85.5% and 33.5% at pH 7.4 afterward 60 h. The difference between the amount of drug released in two nanocomposites related to drug loading capacity demonstrating the impact nanocomposite structure on the smart MOF construction for pH-responsive behavior in vitro. Based on the results, the GO/Cu-TCPP and Fe3O4@Cu3(BTC)2 nanocomposites possess low toxicity and good biocompatibility, but DOX-loaded GO/Cu-TCPP generate better toxicity to cancer cells compared with Fe3O4@Cu3(BTC)2-DOX. Graphical abstract: [Figure not available: see fulltext.] © 2022, Iranian Chemical Society.
Related Docs
View other Related Docs
1. Highly Improved Ph-Responsive Anticancer Drug Delivery and T2-Weighted Mri Imaging by Magnetic Mof Cubtc-Based Nano/Microcomposite, Frontiers in Molecular Biosciences (2023)
2. Cu (Ii)-Porphyrin Metal–Organic Framework/Graphene Oxide: Synthesis, Characterization, and Application As a Ph-Responsive Drug Carrier for Breast Cancer Treatment, Journal of Biological Inorganic Chemistry (2021)
3. Polymer-Coated Nh2-Uio-66 for the Codelivery of Dox/Pcrispr, ACS Applied Materials and Interfaces (2021)
4. Adsorption, Delivery, and Controlled Release of Therapeutic Molecules From Mofs, Metal-Organic Frameworks for Biomedical Applications (2020)
5. Recent Advances in Porphyrin-Based Nanocomposites for Effective Targeted Imaging and Therapy, Biomaterials (2020)
6. Metal-Organic Framework-Based Nanomaterials for Bone Tissue Engineering and Wound Healing, Materials Today Chemistry (2022)
7. Mof As Nanoscale Drug Delivery Devices: Synthesis and Recent Progress in Biomedical Applications, Journal of Drug Delivery Science and Technology (2023)
8. Synthesis of Green Benzamide-Decorated Uio-66-Nh2 for Biomedical Applications, Chemosphere (2022)
Experts (# of related papers)
Rassoul Dinarvand (1)
Seyed Mohsen Ahmadi Tafti (1)
Other Related Docs
9. A Review of Recent Developments of Metal–Organic Frameworks As Combined Biomedical Platforms Over the Past Decade, Advances in Colloid and Interface Science (2023)
10. Label-Free Electrochemical Cancer Cell Detection Leveraging Hemoglobin-Encapsulated Silver Nanoclusters and Cu-Mof Nanohybrids on a Graphene-Assisted Dual-Modal Probe, Scientific Reports (2023)